Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) — The “Microbiome Therapeutics – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
The global market for Microbiome Therapeutics was estimated at US$919.4 Million in 2023 and is projected to reach US$21.5 Billion by 2030, growing at a CAGR of 56.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the Microbiome Therapeutics market is driven by several factors, including the increasing prevalence of chronic diseases linked to dysbiosis of the microbiome, such as diabetes and gastrointestinal disorders. The rising awareness of the importance of gut health in overall well-being and the limitations of current treatments for microbiome-associated conditions also contribute to the market expansion.
Furthermore, substantial investments in microbiome research and the promising outcomes of clinical trials involving microbiome-targeted therapies underline the potential and efficacy of this approach. As regulatory pathways for microbiome therapeutics become clearer and consumer interest in personalized medicine grows, the market is poised for significant growth, reshaping treatment strategies across multiple disease areas.
How are Innovations Driving the Microbiome Therapeutics Market?
Innovations in next-generation sequencing and bioinformatics are driving the microbiome therapeutics market by enabling a deeper understanding of microbial interactions and functions. These technologies allow scientists to identify specific bacterial strains that can be targeted for therapeutic purposes, leading to more precise and effective treatments. Advances in encapsulation and delivery technologies also play a critical role, ensuring that live therapeutic agents reach the appropriate site of action within the human body.
Additionally, collaborations between biotech firms and academic institutions are accelerating the development of novel microbiome-based therapies, bridging the gap between research and clinical application.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the C. Difficile Infection segment, which is expected to reach US$7.3 Billion by 2030 with a CAGR of a 53.2%. The Obesity segment is also set to grow at 56.8% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, which was estimated at $281.3 Million in 2023, and China, forecasted to grow at an impressive 53.4% CAGR to reach $2.8 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Microbiome Therapeutics Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Microbiome Therapeutics Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Microbiome Therapeutics Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as 4D pharma plc, AOBiome, Enterome SA, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 46 Featured):
- 4D pharma plc
- AOBiome
- Enterome SA
- Evelo Biosciences, Inc.
- Ferring International
- Immuron Ltd.
- LNC Therapeutics
- Microbiome Therapeutics, LLC
- Osel, Inc.
- OxThera AB
- Rebiotix, Inc.
- Ritter Pharmaceuticals, Inc.
- Second Genome
- Seres Therapeutics, Inc.
- Vedanta Biosciences, Inc.
- ViThera Pharmaceuticals, Inc.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 196 |
| Forecast Period | 2023-2030 |
| Estimated Market Value (USD) in 2023 | $919.4 Million |
| Forecasted Market Value (USD) by 2030 | $21.5 Billion |
| Compound Annual Growth Rate | 56.9% |
| Regions Covered | Global |
Key Topics Covered
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Global Economic Update
- Microbiome Therapeutics – Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Increasing Understanding of the Human Microbiome Spurs Growth in Therapeutic Development
- Rising Prevalence of Gastrointestinal Disorders Drives Demand for Microbiome Therapeutics
- Advances in Genomic and Metagenomic Technologies Propel Microbiome Research
- Growth in Personalized Medicine Supports Tailored Microbiome Therapeutic Solutions
- Expansion of Clinical Trials Examining Microbiome Applications Strengthens Market Viability
- Increasing Consumer Interest in Probiotic Supplements Influences Microbiome Therapeutic R&D
- Technological Innovations in Microbial Engineering Enhance Therapeutic Efficacy
- Rising Awareness of Antibiotic Resistance Promotes Interest in Microbiome-based Alternatives
- Partnerships Between Biotech Firms and Pharma Drive Advances in Microbiome Therapies
- Emergence of Skin and Oral Microbiome Research Expands Therapeutic Applications
- Investment in Microbiome Startups Signals Growing Market Opportunities
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/sbq8rj
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Microbiome Therapeutics Market
